{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:21:27Z","timestamp":1785842487657,"version":"3.56.0"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1097\/pas.0b013e31819e986a","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T07:19:41Z","timestamp":1248074381000},"page":"1125-1136","source":"Crossref","is-referenced-by-count":44,"title":["Ovarian Pathology in Risk-reducing Salpingo-oophorectomies From Women With BRCA Mutations, Emphasizing the Differential Diagnosis of Occult Primary and Metastatic Carcinoma"],"prefix":"10.1097","volume":"33","author":[{"given":"Joseph T.","family":"Rabban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-May","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine B.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Zaloudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210131","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00000478-200202000-00003","article-title":"Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up","volume":"26","author":"Agoff","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R2-2-20210131","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2559.1996.d01-485.x","article-title":"The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer","volume":"29","author":"Aktepe","year":"1996","journal-title":"Histopathology"},{"key":"R3-2-20210131","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/gyno.1998.5267","article-title":"Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors","volume":"72","author":"Alvarado-Cabrero","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R4-2-20210131","article-title":"AJCC Cancer Staging Manual","year":"2002"},{"key":"R5-2-20210131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ygyno.2005.09.046","article-title":"Comparison of secondary and primary ovarian malignancies reveals differences in their pre- and perioperative characteristics","volume":"101","author":"Antila","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R6-2-20210131","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R7-2-20210131","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0140-6736(01)72307-0","article-title":"On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases","volume":"2","author":"Beatson","year":"1896","journal-title":"Lancet"},{"key":"R8-2-20210131","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1309\/TDP92PQLDE2HLEET","article-title":"Mammaglobin versus GCDFP-15: an immunohistologic validation survey for sensitivity and specificity","volume":"127","author":"Bhargava","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R9-2-20210131","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"R10-2-20210131","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.pgp.0000101082.35393.84","article-title":"Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers","volume":"23","author":"Carcangiu","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R11-2-20210131","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/01.pas.0000202161.80739.ac","article-title":"Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature","volume":"30","author":"Carcangiu","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R12-2-20210131","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.2000.5861","article-title":"Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds","volume":"78","author":"Casey","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R13-2-20210131","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.bjc.6604299","article-title":"The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?","volume":"98","author":"Chan","year":"2008","journal-title":"Br J Cancer"},{"key":"R14-2-20210131","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00004347-200304000-00001","article-title":"Challenges in the early diagnosis and staging of Fallopian-tube carcinomas associated with BRCA mutations","volume":"22","author":"Colgan","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R15-2-20210131","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R16-2-20210131","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer","volume":"5","author":"Crum","year":"2007","journal-title":"Clin Med Res"},{"key":"R17-2-20210131","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R18-2-20210131","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00004347-198706000-00008","article-title":"Secondary ovarian carcinoma: a clinical and pathological evaluation","volume":"6","author":"Demopoulos","year":"1987","journal-title":"Int J Gynecol Pathol"},{"key":"R19-2-20210131","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","article-title":"Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study","volume":"7","author":"Domchek","year":"2006","journal-title":"Lancet Oncol"},{"key":"R20-2-20210131","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"key":"R21-2-20210131","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R22-2-20210131","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/cncr.10741","article-title":"Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18","volume":"95","author":"Fisher","year":"2002","journal-title":"Cancer"},{"key":"R23-2-20210131","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"R24-2-20210131","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/gyno.1995.1278","article-title":"Clinical implications of metastases to the ovary","volume":"59","author":"Fujiwara","year":"1995","journal-title":"Gynecol Oncol"},{"key":"R25-2-20210131","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/1097-0142(19890815)64:4<892::AID-CNCR2820640422>3.0.CO;2-C","article-title":"Ovarian metastases of breast carcinoma. A clinicopathologic study of 59 cases","volume":"64","author":"Gagnon","year":"1989","journal-title":"Cancer"},{"key":"R26-2-20210131","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2005.04.5260","article-title":"ASCO\/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes","volume":"24","author":"Guillem","year":"2006","journal-title":"J Clin Oncol"},{"key":"R27-2-20210131","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1148\/radiology.216.1.r00jl15242","article-title":"Adnexal masses in women with breast cancer: US findings with clinical and histopathologic correlation","volume":"216","author":"Hann","year":"2000","journal-title":"Radiology"},{"key":"R28-2-20210131","first-page":"107","article-title":"Carcinoma of the ovary","volume":"6","author":"Heintz","year":"2001","journal-title":"J Epidemiol Biostat"},{"key":"R29-2-20210131","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"key":"R30-2-20210131","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1200\/JCO.2007.11.3449","article-title":"Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2","volume":"25","author":"Kauff","year":"2007","journal-title":"J Clin Oncol"},{"key":"R31-2-20210131","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0046-8177(90)90128-R","article-title":"The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue","volume":"21","author":"Kennedy","year":"1990","journal-title":"Hum Pathol"},{"issue":"1","key":"R32-2-20210131","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/ijgc-00009577-200602001-00022","article-title":"Metastatic tumors to the ovaries: a study of 170 cases in northern Thailand","volume":"16","author":"Khunamornpong","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R33-2-20210131","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/cncr.22603","article-title":"Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation","volume":"109","author":"Laki","year":"2007","journal-title":"Cancer"},{"key":"R34-2-20210131","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.ajog.2006.03.006","article-title":"Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy","volume":"194","author":"Lamb","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R35-2-20210131","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2007.09.031","article-title":"Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions","volume":"107","author":"Lancaster","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R36-2-20210131","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1309\/QLV6-HH0H-UCTF-WEF6","article-title":"WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids","volume":"117","author":"Lee","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R37-2-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.pap.0000201826.46978.e5","article-title":"Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer","volume":"13","author":"Lee","year":"2006","journal-title":"Adv Anat Pathol"},{"key":"R38-2-20210131","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/1097-0142(197106)27:6<1374::AID-CNCR2820270616>3.0.CO;2-M","article-title":"Significance of ovarian metastasis in therapeutic oophorectomy for advanced breast cancer","volume":"27","author":"Lee","year":"1971","journal-title":"Cancer"},{"key":"R39-2-20210131","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol Oncol"},{"key":"R40-2-20210131","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1525-1438.2006.00287.x","article-title":"Prophylactic salpingo-oophorectomy in 51 women with familial breast-ovarian cancer: importance of fallopian tube dysplasia","volume":"16","author":"Leunen","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R41-2-20210131","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1200\/JCO.2000.18.14.2728","article-title":"Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy","volume":"18","author":"Lu","year":"2000","journal-title":"J Clin Oncol"},{"key":"R42-2-20210131","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/1097-0142(195905\/06)12:3<521::AID-CNCR2820120311>3.0.CO;2-B","article-title":"The incidence of metastases in adrenal glands and ovaries removed for carcinoma of the breast","volume":"12","author":"Lumb","year":"1959","journal-title":"Cancer"},{"key":"R43-2-20210131","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2219::AID-CNCR21>3.0.CO;2-Y","article-title":"A descriptive study of BRCA1 testing and reactions to disclosure of test results","volume":"79","author":"Lynch","year":"1997","journal-title":"Cancer"},{"key":"R44-2-20210131","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R45-2-20210131","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2005.01.024","article-title":"Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer","volume":"97","author":"Meeuwissen","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R46-2-20210131","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0344-0338(97)80076-3","article-title":"Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer","volume":"193","author":"Moll","year":"1997","journal-title":"Pathol Res Pract"},{"key":"R47-2-20210131","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ygyno.2003.12.039","article-title":"Incidence of metastasis to the ovaries from nongenital tract primary tumors","volume":"93","author":"Moore","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R48-2-20210131","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.humpath.2007.09.009","article-title":"Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?","volume":"39","author":"Moritani","year":"2008","journal-title":"Hum Pathol"},{"key":"R50-2-20210131","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.bjc.6601692","article-title":"Clinical outcome of prophylactic oophorectomy in BRCA1\/BRCA2 mutation carriers and events during follow-up","volume":"90","author":"Olivier","year":"2004","journal-title":"Br J Cancer"},{"key":"R51-2-20210131","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/PGP.0b013e31815d05ec","article-title":"Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium","volume":"27","author":"Onuma","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R52-2-20210131","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0090-8258(92)90017-D","article-title":"Nongenital cancers metastatic to the ovary","volume":"44","author":"Petru","year":"1992","journal-title":"Gynecol Oncol"},{"key":"R53-2-20210131","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"J Clin Oncol"},{"key":"R54-2-20210131","first-page":"713","article-title":"Castrating operations associated with metastatic lesions of the breast","volume":"41","author":"Puga","year":"1973","journal-title":"Obstet Gynecol"},{"key":"R55-2-20210131","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/PAS.0b013e31817d74a7","article-title":"Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women with BRCA mutations","volume":"33","author":"Rabban","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R56-2-20210131","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"R57-2-20210131","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/95.14.1072","article-title":"Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study","volume":"95","author":"Rutter","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R58-2-20210131","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archsurg.1941.01210120038004","article-title":"Metastasis of primary carcinoma of breast with special references to spleen, adrenal glands and ovaries","volume":"43","author":"Saphir","year":"1941","journal-title":"Arch Surg"},{"key":"R59-2-20210131","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/cncr.11848","article-title":"Prophylactic oophorectomy: a morphologic and immunohistochemical study","volume":"98","author":"Schlosshauer","year":"2003","journal-title":"Cancer"},{"key":"R60-2-20210131","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ygyno.2006.11.005","article-title":"Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990 to 2003: occurrence, origin and survival compared to ovarian cancer","volume":"105","author":"Skirnisdottir","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R61-2-20210131","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/jnci\/91.7.626","article-title":"Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group","volume":"91","author":"Stratton","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R62-2-20210131","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N Engl J Med"},{"key":"R63-2-20210131","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5858\/2008-132-239-AOEPOB","article-title":"Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors","volume":"132","author":"Takeda","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"R64-2-20210131","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.pas.0000176429.88702.36","article-title":"Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary","volume":"29","author":"Tornos","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R65-2-20210131","first-page":"573","article-title":"Ovarian metastasis of breast carcinoma","volume":"15","author":"Turksoy","year":"1960","journal-title":"Obstet Gynecol"},{"key":"R66-2-20210131","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/1097-0142(19840301)53:5<1164::AID-CNCR2820530523>3.0.CO;2-4","article-title":"Secondary ovarian neoplasia. A clinicopathologic study of 35 cases","volume":"53","author":"Ulbright","year":"1984","journal-title":"Cancer"},{"key":"R67-2-20210131","first-page":"391","article-title":"Cancer metastatic to the ovary: factors influencing survival","volume":"45","author":"Webb","year":"1975","journal-title":"Obstet Gynecol"},{"key":"R68-2-20210131","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0002-9378(70)90586-7","article-title":"Metastatic ovarian tumors","volume":"107","author":"Woodruff","year":"1970","journal-title":"Am J Obstet Gynecol"},{"key":"R69-2-20210131","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0090-8258(03)00075-1","article-title":"Metastatic ovarian tumors: a review of 64 cases","volume":"89","author":"Yada-Hashimoto","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R70-2-20210131","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/1097-0142(19810701)48:1<210::AID-CNCR2820480133>3.0.CO;2-H","article-title":"Breast carcinoma masquerading as primary ovarian neoplasm","volume":"48","author":"Young","year":"1981","journal-title":"Cancer"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000478-200908000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T21:10:51Z","timestamp":1633727451000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-200908000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":69,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e31819e986a","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}